Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Christopher DeGrande
CMS Proposes Sweeping Restrictions On Remote Patient Monitoring: The Outsourcing Ban, Reimbursement
CMS’s CY 2027 Proposed Rule would significantly restrict Medicare reimbursement for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), including banning outsourced clinical staffing, adding new patient-relationship and initiating-visit requirements, reducing certain reimbursement rates, and exploring consolidation of existing billing codes. CMS is turning years of OIG scrutiny and enforcement activity into formal payment policy.
California Enacts SB 351: New Restrictions On Private Equity And Hedge Fund Involvement In Physician And Dental Practices
Benesch Friedlander Coplan & Aronoff LLP are most popular: within Consumer Protection, Real Estate and Construction and Insolvency/Bankruptcy/Re-Structuring topic(s) Key Takeaways Codification of CPOM Restrictions: SB 351 (effective January 1, 2026) codifies and expands California's corporate practice of medicine/dentistry rules, specifically targeting private equity and hedge fund involvement in physician and dental practices.
OIG and DOJ Intensify Remote Patient Monitoring Oversight: 2025 Data Snapshot, FCA Settlement and the Emerging Enforcement Playbook | JD Supra
Key Takeaways Federal oversight of Remote Patient Monitoring (“RPM”) is increasing, as agencies like the OIG, CMS and DOJ shift from issuing warnings to actively enforcing regulations. This includes standardized audit metrics and the first False Claims Act (“FCA”) settlement related to RPM billing. The risk of audits, investigations and significant financial penalties is now much higher for RPM stakeholders.
CMS Proposes Comprehensive Updates to Remote Patient Monitoring and Remote Therapeutic Monitoring Reimbursement | JD Supra
These proposals represent CMS’s most significant effort yet to recalibrate remote monitoring reimbursement. By lowering billing thresholds and introducing new code families, CMS aims to reduce operational barriers, expand clinical applicability, and reinforce its policy goal of shifting care delivery toward preventive and value-based models. I. Proposed RPM and RTM Changes A. Device Supply and Data Transmission Current Standard: At least 16 days of data transmission per 30-day period (CPT 99454).
CMS's CY 2026 Fee Schedule Proposal: MSSP Reforms Take Center Stage In Push Toward Value
On July 14, 2025, the Centers for Medicare & Medicaid Services ("CMS") released the proposed rule for the Calendar Year ("CY") 2026 Medicare Physician Fee Schedule ("PFS"), formally titled CMS-1832-P. The proposed rule outlines key payment policy updates for Medicare Part B services, including changes to physician reimbursement rates, modifications to the Quality Payment Program ("QPP"), and significant structural reforms to the Medicare Shared Savings Program ("MSSP").
CMS’s CY 2026 Fee Schedule Proposal: MSSP Reforms Take Center Stage in Push Toward Value | JD Supra
While CMS has framed these updates as routine adjustments, several underlying proposals suggest a broader strategic shift toward performance-based payment and accountability, particularly within the MSSP and advanced Alternative Payment Models (“APMs”). The rule also includes targeted modifications to practice expense methodology and physician quality measurement intended to enhance cost alignment and clinical reporting flexibility. Highlights from the rule are detailed below.
CMS Launches WISeR Model: A Technology-Enabled Effort to Reduce Wasteful Medicare Spending | JD Supra
Two key takeaways from the WISeR Model are: (1) participating technology vendors will be eligible for performance-based compensation through a shared savings methodology, with payments based on cost reductions as determined by CMS; and (2) participation is voluntary for healthcare providers, who may choose whether to engage with the model’s prior authorization process or continue under existing post-payment review protocols.
Healthcare Private Equity Investment: As Federal Headwinds Subside, A Gale Warning Goes Up In Many States
Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency. As "headwinds" mount, particularly at the state level, PE firms and the healthcare businesses in which they invest must be prepared to adapt their consolidation strategies.
Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States | JD Supra
Federal Regulation and Legislation Related to Healthcare PE Will Likely Decrease At the federal level, agencies such as the Federal Trade Commission (FTC) and the Department of Justice (DOJ) have heightened their oversight of PE activities in healthcare in recent years. In March 2024, the FTC conducted a workshop examining private equity’s influence in the sector, expressing concerns over investment strategies that could undermine competition and affect care quality.
Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States
Federal Regulation and Legislation Related to Healthcare PE Will Likely Decrease At the federal level, agencies such as the Federal Trade Commission (FTC) and the Department of Justice (DOJ) have heightened their oversight of PE activities in healthcare in recent years. In March 2024, the FTC conducted a workshop examining private equity's influence in the sector, expressing concerns over investment strategies that could undermine competition and affect care quality.
Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States
Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency. As “headwinds” mount, particularly at the state level, PE firms and the healthcare businesses in which they invest must be prepared to adapt their consolidation strategies.
Dialysis & Nephrology Digest - December 2023 | JD Supra
December 11, 2023 Jake Cilek, Lauri Cooper, Christopher DeGrande, Scott Downing, Jason Greis, Juan Morado Jr., Nesko Radovic Benesch + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: Fresenius continues business consolidation with sale of fertility business for $545M - A consortium consisting of KKR portfolio company IVI RMA and Spanish PE firm GED Capital agreed to pay €500 million for Eugin Group, Fresenius’ fertility business.
Benesch DSO Intelligence Quarterly Report: Q3 2023 | JD Supra
Profitable Dental Practices Push to Increase Patient Satisfaction Through Automation - A report by NexHealth, a digital scheduling platform, conducted a survey to determine the state of the dental industry in 2023 by surveying more than 500 dental professionals. The report found that 60% of its “Elite practice” clients reported revenue growth in 2023, and 57% predicted that growth would continue through the year.
Dialysis & Nephrology Digest - November 2023 | JD Supra
Fresenius hiring Ascension Capital exec to head care delivery - The appointment of Craig Cordola as CEO of the dialysis company’s care delivery segment takes effect Jan. 1. He was at Ascension Capital for the past six years, where he’s currently EVP, responsible for strategic investments. Cordola is replacing Bill Vale, who’s retiring from Fresenius at the end of the year. Please see full publication below for more information. Download PDF
Dialysis & Nephrology Digest - October 2023 | JD Supra
Federal Law increases competition in organ procurement, transplant system; NKF, ASN approve - The President signed the bipartisan bill into law on Sept. 22. The Organ Procurement and Transplantation Network (OPTN) was operated by a single non-profit for nearly four decades, but has been criticized for failing to put a dent in transplant wait lists, which typically exceeds 100,000.
Dialysis & Nephrology Digest - September 2023 | JD Supra
FTC, DoJ propose changes to HSR Act for more effective, efficient merger reviews - The FTC, along with the Assistant Attorney General of the Antitrust Division, proposed changes to the premerger notification form and associated instructions, as well as the premerger notification rules implementing the Hart-Scott Rodino Act. The proposed changes will enable agencies to screen transactions for competition issues more effectively and efficiently. Please see full Newsletter below for more information.
Dialysis & Nephrology Digest - August 2023 | JD Supra
NY non-compete ban still receiving pushback as Governor waits to sign off - While NY Governor Kathy Hochul waits to sign off on one of the country’s toughest bans on non-compete agreements, many lobby groups from the financial industry and other business associations are pushing the government to include some exceptions.
Benesch DSO Intelligence Quarterly Report: Q2 2023 | JD Supra
Younger Dentists are Affiliating with DSOs at Higher Rates in the U.S. Financial constraints, stronger need for work/life balance is driving this trend - The ADA Health Policy Institute (HPI) released data in May that found 13% of dentists in the U.S. had affiliated with a DSO organization in 2022, and for dentists less than 10 years out of dental school, the rate was significantly higher, at 23%. The current data is up from a rate of 10.4% in 2019 and 8.8% in 2017.
Dialysis & Nephrology Digest - July 2023 | JD Supra
Benesch: NLRB decision overturns use of ‘entrepreneurial opportunity’ super factor for classifying employees - Benesch explains the labor board’s decision retains the 10-point test to determine who can be considered an employee and who’s an independent contractor. However, it overturns a Trump-era ruling which required the concept of “entrepreneurial opportunity,” rather than actual entrepreneurial activity, to take precedence.
Dialysis & Nephrology Digest - June 2023 | JD Supra
Benesch: MN ban on non-compete agreements includes carveout for business sale, dissolution - Benesch Law notes the bill only awaits the signature of MN’s Governor and could become law as early as July 1.
Dialysis & Nephrology Digest - May 2023 | JD Supra
MedPAC recommends no additional increase in payments for dialysis in 2024 - MedPAC’s report on outpatient dialysis services recommends Congress not increase Medicare payments for dialysis services next year beyond the 1.8% boost previously announced.
Benesch DSO Intelligence Quarterly Report: Q1 2023 | JD Supra
Dental practice consolidation to continue in 2023 despite economic uncertainty - Despite the rapid increase in consolidation in the past decade, analysts believe that it is only the beginning for the DSO industry, with some stating that the number of DSOs will triple over the next 10 to 15 years, as the trend of practice consolidation accelerates. The DSO industry is about 20-30% consolidated, but that is projected to jump to 60-70% in the next decade.
Dialysis & Nephrology Digest - April 2023 | JD Supra
ME trial reminiscent of DaVita anti-poaching case that also ended in acquittal; DOJ strategy questioned - In Apr. 2022, juries in TX and CO acquitted healthcare companies charged by the DOJ’s Antitrust Division. In the CO case, DaVita and its former CEO were found not guilty of conspiring with other companies not to hire each other’s top executives.
Dialysis & Nephrology Digest - March 2023 | JD Supra
Correction to our January 31, 2023 newsletter article, “Dialysis Provider Satellite Healthcare Reports Data Breach Affecting Nearly 100k Patients”: Media Statement, Satellite Healthcare - In January 2023, Satellite Healthcare made its annual report, as required, of all potential inappropriate uses of protected health information. One such breach occurred in Texas when staff manually pulled and reported a list of patients to a Covered Entity Healthcare Provider.
Dialysis & Nephrology Digest - January 2023 #2 | JD Supra
Benesch: Changes to state laws mean IL employers should review their employment practices - In IL, legislation affecting workplaces went into effect at the beginning of the year, including: ..The minimum wage was increased to $13/hr (with exceptions for workers under age 18 and those who receive tips); ..The Family Bereavement Leave Act broadens the scope of reasons workers can book up to 10 days of unpaid time off; ..The Human Rights Act was amended, so hair textures and styles associated...
Dialysis & Nephrology Digest - January 2023 | JD Supra
Federal omnibus spending bill rolls back some Medicare payment cuts scheduled for 2023, 2024 - Buried within the $1.7-trillion spending package signed by the President on Dec. 29 was partial relief for a planned 4.5% cut in payments to physicians under the CMS’ 2023 Physician Fee Schedule. Congress agreed the fee cut this year will total 2% and 3.5% in 2024. RPA notes the Medicare conversion factor for this year is pegged at $33.8872.
Dialysis & Nephrology Digest - December 2022 | JD Supra
Benesch: AKS claims against Azura dropped; FCA allegations to continue with DOJ intervention - The DOJ filed an Amended Intervenor Complaint in Aug.
Benesch DSO Intelligence Bi-Monthly Report: September - November 2022 | JD Supra
AI can improve dental services by complimenting, not eliminating, human performance - Artificial Intelligence (AI) is playing an increasingly important role across a variety of industries and can benefit dental practices in new ways, according to a report by Glidewell, a dental materials and device manufacturer based in Newport Beach, Calif.. The company has reached a point where its software can generate crown proposals with a 98% acceptance rate.
Dialysis & Nephrology Digest - November 2022 | JD Supra
Benesch: DOL proposed rule aims to clarify independent contractor classification - The Department of Labor (DOL) proposes changes to the Fair Labor Standards Act to clarify the difference between an independent contractor and an employee. Currently, two metrics are given precedence when applying the independent contractor rule: the nature and degree of the worker’s control over the work and the worker’s opportunity for profit or loss based on personal initiative or investment.
Dialysis & Nephrology Digest - October 2022 | JD Supra
Benesch outlines five states with data protection laws coming into effect in 2023 - Next year, statutes for data security and data privacy will go into effect in CA and VA on Jan. 1, while laws in CO and CT will be effective as of July 1 and entities operating in UT will be subject to its legislation as of Dec. 31. Benesch Law says the scope of the various laws are as follows... Please see full Publication below for more information. Download PDF
Benesch DSO Intelligence Bi-Monthly Report: July - September 2022 | JD Supra
Insurance reimbursements remained stagnant despite higher operating costs for dental practices - According to an August poll by the American Dental Association’s Health Policy Institute, insurance reimbursements have not risen for the majority of dentists, despite rising costs. The Health Policy Institute surveyed about 1,200 dentists on their operating expenses and found they have reported increased costs for supplies, staff wages, PPE, equipment and rent to name a few.
Dialysis & Nephrology Digest - September 2022 | JD Supra
Fresenius CEO resigning; to be replaced by head of company’s pharmaceutical business - Michael Sen, President and CEO of Fresenius Kabi, will replace Stephan Sturm as CEO of Fresenius SE on Oct. 1. Shares in the company fell 44% over the past year, in part due to the COVID pandemic and a surge of costs but Fresenius’ stock price rose by nearly 6% immediately after Sturm’s announcement.
Dialysis & Nephrology Digest - August 2022 | JD Supra
DOJ files civil complaint alleging Fresenius performed unnecessary procedures on dialysis patients - In June, it was revealed that DOJ would partially join a whistleblower lawsuit against the dialysis provider. In a civil complaint filed July 12, the department alleges Fresenius subsidiary Azura Vascular Care of violating the False Claims Act by performing medically unnecessary procedures on dialysis patients at nine locations in NY.
Benesch DSO Intelligence Bi-Monthly Report: May - July 2022 | JD Supra
Court Square Capital acquisition of West Coast Dental could fuel M&A in Calif. and neighboring states - The acquisition was reportedly valued around $250 million and plans for the acquisition include accelerating new de novo clinic openings in Los Angeles, which industry experts say could potentially fuel M&A throughout California and neighboring states. Ongoing fragmentation in the dental sector space has persisted despite a strong private equity appetite for scaled dental platforms.
Dialysis & Nephrology Digest - July 2022 | JD Supra
SCOTUS sides with OH-based medical plan in dispute with DaVita over dialysis reimbursements - In a 7-2 vote, the Supreme Court ruled in favor of the Marietta Memorial Hospital Employee Benefit Plan in a case that hinged on a Medicare rule prohibiting different levels of coverage for patients with ESRD and those without. DaVita accused the plan of discrimination, saying it was forcing members with ESRD off their private plan and onto Medicare by lowering reimbursements.
Dialysis & Nephrology Digest - June 2022 | JD Supra
Medtronic, DaVita forming kidney tech company to develop dialysis delivery systems - The healthtech and the dialysis provider will be 50-50 partners in the venture, which will include the entirety of Medtronic’s renal care business: renal access and acute and chronic therapy devices, as well as pipeline products, R&D teams and manufacturing facilities. However, Medtronic notes that neither the AV access portfolio nor the peripheral vascular health business are included in the collaboration.
Benesch DSO Market Intelligence Bi-Monthly Report: March - May 2022 | JD Supra
Dentists continue to shift toward DSO-supported practices amid ongoing labor challenges - According to the American Dental Association, DSO-supported practices are now considered one of the fastest growing practice models in dentistry. The ADA Health Policy Institute estimates that solo practices are becoming less and less common, and more dentists are gravitating toward large group practices.
Dialysis & Nephrology Digest - May 2022 | JD Supra
Denver jury acquits DaVita, former CEO, of all charges in antitrust trial - After two days of deliberations, a Denver jury found DaVita and former CEO Kent Thiry not guilty of all charges relating to charges they conspired with competitors not to hire each other’s senior managers. The Department of Justice argued the dialysis provider’s nonpoaching agreement violated the Sherman Anti-trust Act and considered DaVita a test case ahead of other possible criminal charges in similar instances.
Dialysis & Nephrology Digest - April 2022 | JD Supra
SCOTUS questions appear to support DaVita’s position in dialysis care discrimination case - Private plans are supposed to provide coverage for dialysis for the first 30 months before the patients can transition to Medicare and there’s a statutory framework in place to ensure plans don’t lowball reimbursement. On Mar. 1, SCOTUS heard verbal arguments in the case Marietta Memorial Hospital Employee Health Benefit Plan v.
Benesch Healthcare+ Dialysis & Nephrology Digest No. 27 - Food, Drugs, Healthcare, Life Sciences - United States
Benesch Friedlander Coplan & Aronoff United States: Benesch Healthcare+ Dialysis & Nephrology Digest No. 27 11 April 2022 by Jake A. Cilek , Christopher DeGrande , Scott P. Downing , Jason S.
Benesch DSO Market Intelligence Bi-Monthly Report: January - March 2022 | JD Supra
ADA, coalition thanks lawmakers for passing bill aimed at preventing burnout among health workers as pandemic-related challenges continue to affect industry - The ADA and 70 stakeholders praised Congress for passing the Dr. Lorna Breen Health Care Provider Protection Act, legislation that will give healthcare workers better access to education and training in order to prevent stress and burnout.
Benesch Healthcare+ Dialysis & Nephrology Digest No. 26
Benesch Friedlander Coplan & Aronoff United States: Benesch Healthcare+ Dialysis & Nephrology Digest No. 26 22 March 2022 by Jake A. Cilek , Christopher DeGrande , Scott P. Downing , Jason S. Greis and Juan Morado Jr. Benesch Friedlander Coplan & Aronoff To print this article, all you need is to be registered or login on Mondaq.com. Nephrology and Dialysis Practices MARCH 1, 2022 CMS calls for applications for second cohort of KCC Model; deadline set for Mar.
Dialysis & Nephrology Digest - March 2022 | JD Supra
CMS calls for applications for second cohort of KCC Model; deadline set for Mar. 25 - The Center for Medicare and Medicaid Innovation says performance period participation agreements for the CMS Kidney Care First Option and Comprehensive Kidney Care Contracting Options of the KCC Model are available for the cohort beginning Jan. 1, 2023. CMS Innovation states the applications have a term of four performance years, 2023 through 2026.
Dialysis & Nephrology Digest - February 2022 | JD Supra
Benesch: SCOTUS decisions on COVID-19 vaccine mandates have repercussions for employers, healthcare facilities The Supreme Court decided two cases relating to COVID-19 vaccination mandates. In the first case, SCOTUS ruled 6-3 that effectively ended the Occupational Safety and Health Administration (OSHA) vaccinate-or-test policy in workplaces with at least 100 employees. The majority felt OSHA’s mandate to regulate occupational dangers didn’t extend to more broad public health measures.
Benesch DSO Market Intelligence Bi-Monthly Report: November 2021 - January 2022 | JD Supra
Nationwide poll on COVID-19 impacts in dentistry find lowest ‘open as usual’ rate since March - According to the American Dental Association’s COVID-19 impact poll for the week of Dec. 13, 60.5% of organizations categorized as DSOs reported they were ‘open as usual’ with 39.5% saying they were open but with lower patient volumes than usual. The last time DSOs reported a lower volume was in March 2021, when 40% were open but with lower patient volumes than usual.
Dialysis & Nephrology Digest - January 2022 | JD Supra
Benesch reviews state, federal modifications to restrictive covenant laws - In a “Year-End Review,” Benesch points out there was considerable activity in trade secret and restrictive covenant law in 2021. Some of the highlights include: ..N.Y. tried to join the other 49 states in adopting the Uniform Trade Secret Acts and tabled two bills relating to non-compete agreements but none of the proposed laws made it through the state legislature; ..Nev.
Dialysis & Nephrology Digest - December 2021 | JD Supra
SCOTUS to consider case alleging private plan’s ESRD coverage violates MSPA - The Supreme Court agreed to hear the case of Marietta Memorial Hospital Employee Health Benefits Plan v. DaVita, which alleges a private healthcare plan treats members with ESRD differently than those with other conditions. In the petition, the plaintiff, DaVita, contends the Marietta Memorial Hospital’s employee plan discriminates against ESRD members, which is prohibited under the Medicare Secondary Payer Act (MSPA).
Benesch DSO Newsletter - Q4 2021 | JD Supra
Teledentistry M&As aim to increase access to on-demand virtual dental care - According to the American Dental Association (ADA), every 15 seconds, a person enters an Emergency Room with a dental emergency, costing the healthcare industry $2 Billion yearly. The ADA estimated that that 79% of the over 2.2 million preventable ER dental visits, 79% of which could have been better addressed by a visit to a local dentist and most of these emergencies can be managed with a virtual visit.
Dialysis & Nephrology Digest - November 2021 | JD Supra
Carolina Kidney Partners: Addition of Ga.-based nephrology practice expands Medicare, commercial insurance footprint - Savannah’s Nephrology & Hypertension Medical Associates operates seven clinics in Ga. and S. Car. Carolina Kidney Partners (CKP) says it’ll be responsible for care coordination, which includes data analytics and value-based contracting.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Christopher
Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack